Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Circulating immune complexes in patients with malignant diseases].

J S Smolen, E J Menzel, P Aiginger

Acta Medica Austriaca. Supplement

|January 1, 1979

Summary

Circulating immune complexes (CICs) were studied in various cancers. Carcinomas showed a higher CIC incidence than lymphatic system malignancies, but findings varied by cancer type and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.

Scandinavian journal of rheumatology·2020

Same author

Preface.

Seminars in arthritis and rheumatism·2019

Same author

Etanercept therapy leads to reductions in matrix metalloproteinase-3 in patients with erosive hand osteoarthritis.

Scandinavian journal of rheumatology·2019

Same author

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018

Same author

Advances in targeted therapies 2017.

Clinical immunology (Orlando, Fla.)·2018

Same author

Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition.

Arthritis research & therapy·2017

Area of Science:

Immunology
Oncology

Context:

Solid phase C1q assay used to detect circulating immune complexes (CICs).
Study included patients with Hodgkin's disease, testicular malignancies, and other carcinomas.

Purpose:

To investigate the presence and potential prognostic value of CICs in patients with various malignancies.

Summary:

CICs were detected in Hodgkin's disease patients only during chemotherapy, with poor outcomes.
In testicular cancer, CICs were more prevalent in patients without metastatic disease.
Carcinomas exhibited a significantly higher incidence of CICs compared to lymphatic system malignancies.

Impact:

Findings suggest varying roles of CICs across different cancer types.

Related Experiment Videos

Highlights the need to consider different types of immune complexes beyond C1q binding.